Wall Street Experts
ver. ZuMIgo(08/25)
Prognozy (mln) dla Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.
Okres |
2023-12-31 |
2023-12-31 |
2024-12-31 |
2024-12-31 |
2025-12-31 |
2025-12-31 |
2026-12-31 |
2026-12-31 |
2027-12-31 |
2027-12-31 |
Przychód (średnia) |
1,036.00 |
1,036.00 |
1,673.26 |
1,673.26 |
2,239.09 |
2,239.09 |
2,946.69 |
2,946.69 |
3,865.55 |
3,865.55 |
Przychód Δ r/r |
-73.20% |
0.00% |
61.51% |
61.51% |
33.82% |
33.82% |
31.60% |
31.60% |
31.18% |
31.18% |
Przychód (min) |
1,034.77 |
1,034.77 |
1,572.18 |
1,572.18 |
2,200.21 |
2,200.21 |
2,843.09 |
2,843.09 |
3,767.37 |
3,767.37 |
Przychód (max) |
1,037.23 |
1,037.23 |
1,803.22 |
1,803.22 |
2,260.70 |
2,260.70 |
3,130.10 |
3,130.10 |
3,963.74 |
3,963.74 |
EBITDA (średnia) |
386.61 |
386.61 |
624.42 |
624.42 |
835.57 |
835.57 |
1,099.63 |
1,099.63 |
1,442.53 |
1,442.53 |
EBIT (średnia) |
241.43 |
241.43 |
389.94 |
389.94 |
521.81 |
521.81 |
686.71 |
686.71 |
900.84 |
900.84 |
EBIT % |
23.30% |
23.30% |
23.30% |
23.30% |
23.30% |
23.30% |
23.30% |
23.30% |
23.30% |
23.30% |
Zysk netto (średni) |
116.56 |
116.56 |
299.06 |
299.06 |
395.60 |
395.60 |
517.81 |
517.81 |
653.85 |
653.85 |
Zysk netto % |
11.25% |
11.25% |
17.87% |
17.87% |
17.67% |
17.67% |
17.57% |
17.57% |
16.91% |
16.91% |
EPS (średnia) |
0.53 |
0.53 |
1.35 |
1.35 |
1.80 |
1.80 |
2.36 |
2.36 |
3.02 |
3.02 |
Liczba analityków (Przychody) |
2 |
2 |
5 |
5 |
3 |
3 |
4 |
4 |
3 |
3 |
Liczba analityków (EPS) |
2 |
2 |
5 |
5 |
3 |
3 |
4 |
4 |
3 |
3 |
symbol |
688076.SS |
688076.SS |
688076.SS |
688076.SS |
688076.SS |
688076.SS |
688076.SS |
688076.SS |
688076.SS |
688076.SS |